Figure 2 shows the process of CRC screening and the distribution of population screening data based on national periodical examinations of f-Hb levels, including the numbers of screening-detected CRC and clinically detected CRC, advanced adenoma, nonadvanced adenoma, and normal subjects. The gene discussed is GSTM1; the disease is colorectal carcinoma.